Deletion of DYRK1A Accelerates Osteoarthritis Progression Through Suppression of EGFR-ERK Signaling

Area of Science:

• Biochemistry
• Cell Biology
• Orthopedics

Background:

• Dual-specificity tyrosine phosphorylation regulated kinase 1A (DYRK1A) signaling influences the balance of catabolism and anabolism in articular chondrocytes.
• Osteoarthritis (OA) pathogenesis involves dysregulation of chondrocyte function.

Purpose of the Study:

• To investigate the role and mechanism of DYRK1A in osteoarthritis pathogenesis.
• To determine the impact of DYRK1A on chondrocyte catabolism and anabolism in OA.

Main Methods:

• Detected DYRK1A and epidermal growth factor receptor (EGFR) expression in OA cartilage from mice and patients.
• Utilized chondrocyte-specific knockout DYRK1A (DYRK1A-cKO) mice to assess OA progression after destabilized medial meniscus (DMM) surgery.
• Histologically scored knee cartilage and analyzed EGFR signaling inhibition in DYRK1A-cKO chondrocytes.

Main Results:

• Downregulation of DYRK1A and EGFR signaling observed in trauma-induced OA mice and OA patients.
• Conditional DYRK1A deletion exacerbated DMM-induced cartilage degeneration, reduced cartilage thickness, and increased chondrocyte hypertrophy.
• Collagen type II, p-ERK, and aggrecan expression decreased, while collagen type X expression increased in DYRK1A-deleted cartilage.

Conclusions:

• DYRK1A plays a protective role in delaying knee osteoarthritis progression in mice.
• DYRK1A maintains EGFR-ERK signaling, which is crucial for preserving articular chondrocyte function and cartilage integrity.
• Targeting DYRK1A or its downstream signaling pathways may offer therapeutic strategies for osteoarthritis.